SARS-CoV-2 Testing in Florida, Illinois, and Maryland: Access and Barriers
View ORCID ProfileSteven J. Clipman, View ORCID ProfileAmy Wesolowski, View ORCID ProfileShruti H. Mehta, View ORCID ProfileSmisha Agarwal, View ORCID ProfileSarah E. Cobey, View ORCID ProfileDerek A.T. Cummings, View ORCID ProfileDustin G. Gibson, View ORCID ProfileAlain B. Labrique, Gregory D. Kirk, View ORCID ProfileSunil S. Solomon
doi: https://doi.org/10.1101/2020.12.23.20248789
Steven J. Clipman
1Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
Amy Wesolowski
2Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
Shruti H. Mehta
2Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
Smisha Agarwal
1Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
Sarah E. Cobey
3Department of Ecology and Evolution, University of Chicago, Chicago, Illinois, United States of America
Derek A.T. Cummings
4Department of Biology and the Emerging Pathogens Institute, University of Florida, Gainesville, Florida, United States of America
Dustin G. Gibson
1Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
Alain B. Labrique
1Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
2Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
Gregory D. Kirk
2Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
5Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
Sunil S. Solomon
2Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
5Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
Article usage
Posted December 24, 2020.
SARS-CoV-2 Testing in Florida, Illinois, and Maryland: Access and Barriers
Steven J. Clipman, Amy Wesolowski, Shruti H. Mehta, Smisha Agarwal, Sarah E. Cobey, Derek A.T. Cummings, Dustin G. Gibson, Alain B. Labrique, Gregory D. Kirk, Sunil S. Solomon
medRxiv 2020.12.23.20248789; doi: https://doi.org/10.1101/2020.12.23.20248789
SARS-CoV-2 Testing in Florida, Illinois, and Maryland: Access and Barriers
Steven J. Clipman, Amy Wesolowski, Shruti H. Mehta, Smisha Agarwal, Sarah E. Cobey, Derek A.T. Cummings, Dustin G. Gibson, Alain B. Labrique, Gregory D. Kirk, Sunil S. Solomon
medRxiv 2020.12.23.20248789; doi: https://doi.org/10.1101/2020.12.23.20248789
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (710)
- Anesthesia (201)
- Cardiovascular Medicine (2944)
- Dermatology (249)
- Emergency Medicine (440)
- Epidemiology (12750)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4586)
- Geriatric Medicine (419)
- Health Economics (729)
- Health Informatics (2918)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (426)
- Medical Ethics (115)
- Nephrology (469)
- Neurology (4359)
- Nursing (236)
- Nutrition (639)
- Oncology (2271)
- Ophthalmology (647)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1197)
- Primary Care Research (496)
- Public and Global Health (6944)
- Radiology and Imaging (1529)
- Respiratory Medicine (915)
- Rheumatology (438)
- Sports Medicine (385)
- Surgery (489)
- Toxicology (60)
- Transplantation (212)
- Urology (181)